AACR: Exosome-Based miRNA Assay Can Detect Pancreatic Cancer
By Elana Gotkine HealthDay Reporter
MONDAY, April 8, 2024 -- An exosome-based liquid biopsy assay can distinguish patients with pancreatic ductal adenocarcinoma (PDAC) from healthy donors (HDs), according to a study presented at the annual meeting of the American Association for Cancer Research, held from April 5 to 10 in San Diego.
Caiming Xu, M.D., Ph.D., from the Beckman Research Institute of The City of Hope in Monrovia, California, and colleagues performed a real-time quantitative polymerase chain reaction-based assay using the plasma biospecimen from four prospective cohorts. The performance of the microRNA (miRNA) signature was also examined in conjunction with plasma CA19-9 for detecting early-stage PDAC.
The researchers found that two distinct panels of cell-free-miRNAs and exosomal-miRNAs robustly distinguished patients with PDAC from HDs in the training cohort from Japan. The signature resulting from combining these panels exhibited a notable ability to distinguish PDAC from HD with substantial accuracy in the training cohort (area under the curve [AUC], 0.98). This signature was successfully validated and evaluated in three independent cohorts from the United States, Korea, and China (AUCs, 0.93, 0.91, and 0.88, respectively). When the signature was combined with CA19-9 in the U.S. cohort, the overall diagnostic performance of this liquid biopsy assay significantly improved early detection of PDAC (AUC, 0.97; sensitivity and specificity, 0.95 and 0.96, respectively).
"We have established an exosome-based signature that combines exosomal microRNAs and cell-free DNA to robustly identify patients with early-stage pancreatic cancer," Xu said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Long COVID Definitions, Care Models Are Evolving
MONDAY, May 20, 2024 -- Definitions of long COVID and care models are evolving, but considerable variability is seen in these models, according to a review published online May 21...
Recommendations Developed for People With HIV Wanting to Breastfeed
MONDAY, May 20, 2024 -- In an American Academy of Pediatrics clinical report published online May 20 in Pediatrics, recommendations are presented for breastfeeding among people...
Social Determinants of Health Impact Poststroke Mortality Risk
MONDAY, May 20, 2024 -- Social determinants of health have a cumulative impact on poststroke mortality, according to a study presented at the the annual European Stroke...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.